Company intelligence / Profile preview

Nomic Bio

Montreal, Quebec, Canadanomic.bio ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Nomic Bio has developed the nELISA platform—a next-generation multiplexed immunoassay that allows high-throughput profiling of hundreds to thousands of proteins per sample at significantly lower cost and higher speed than traditional ELISAs. Their technology enables robust immune secretome profiling for drug discovery and biomarker validation. The company’s solutions are used by pharmaceutical companies and biotechs for large-scale protein analysis supporting both basic science and translational applications. They have raised over $59M in funding with strong investor backing.

Therapeutic areas: Oncology
Modalities: Device (platform for protein measurement)Nanotechnology-based assay systemImmunoassay technology (nELISA platform)
Industry: Protein Biomarker Diagnostics

Partnerships

Early access programs with high-throughput screening groups at top pharmaceutical companies and pioneering biotech firms; specific partners are undisclosed but include major pharma clients.

Beyond the preview

Go deeper on Nomic Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nomic Bio.

Explore the full profile